RESUMO
Traumatic brain injury (TBI) is an alteration of brain function caused by a sudden transmission of an external force to the head. The biomechanical impact induces acute and chronic metabolic changes that highly contribute to injury evolution and outcome. TBI heterogeneity calls for approaches allowing the mapping of regional molecular and metabolic changes underpinning disease progression, with mass spectrometry imaging (MSI) as an efficient tool to study the spatial distribution of small metabolites. In this study, we applied an innovative targeted atmospheric pressure-MALDI mass spectrometry imaging (AP-MALDI MSI) approach, starting from an extensive list of metabolites, representative of different metabolic pathways, individually validated on the tissue under analysis with original standards using 2,5-dihydroxybenzoic acid (DHB), to characterize the impact of TBI on regional changes to small metabolites in the brain. Brains from sham and TBI mice obtained 21 days post-injury were analyzed to examine the spatial metabolic profile of small metabolites belonging to different metabolic pathways. By a whole brain analysis, we identified four metabolites (alanine, lysine, histidine, and inosine) with higher abundance in TBI than sham mice. Within the TBI group, lysine, histidine, and inosine were higher in the hemisphere ipsilateral to the biomechanical impact vs. the contralateral one. Images showed a major involvement of the ipsilateral thalamus characterized by the increase of arginine, lysine, histidine, and inosine and a significant reduction of glutamic acid, and N-acetylaspartic acid compared to the contralateral thalamus. These findings indicate high-resolution imaging mass spectrometry as a powerful tool to identify region-specific changes after a TBI to understand the metabolic changes underlying brain injury evolution.
Assuntos
Lesões Encefálicas Traumáticas , Espectrometria de Massas por Ionização e Dessorção a Laser Assistida por Matriz , Lesões Encefálicas Traumáticas/metabolismo , Animais , Camundongos , Espectrometria de Massas por Ionização e Dessorção a Laser Assistida por Matriz/métodos , Masculino , Camundongos Endogâmicos C57BL , Encéfalo/metabolismoRESUMO
Background: Epithelial ovarian cancer is associated with high mortality due to diagnosis at later stages associated with peritoneal involvement. Several trials have evaluated the effect of intraperitoneal treatment. In this preclinical study, we report the efficacy, pharmacokinetics and pharmacodynamics of intraperitoneal treatment with two approved nanomolecular formulations of paclitaxel (nab-PTX and mic-PTX) in a murine ovarian cancer xenograft model. Methods: IC50 was determined in vitro on three ovarian cancer cell lines (OVCAR-3, SK-OV-3 and SK-OV-3-Luc IP1). EOC xenografts were achieved using a modified subperitoneal implantation technique. Drug treatment was initiated 2 weeks after engraftment, and tumor volume and survival were assessed. Pharmacokinetics and drug distribution effects were assessed using UHPLC-MS/MS and MALDI imaging mass spectrometry, respectively. Pharmacodynamic effects were analyzed using immunohistochemistry and transmission electron microscopy using standard protocols. Results: We demonstrated sub-micromolar IC50 concentrations for both formulations on three EOC cancer cell lines in vitro. Furthermore, IP administration of nab-PTX or mic-PTX lead to more than 2-fold longer survival compared to a control treatment of IP saline administration (30 days in controls, 66 days in nab-PTX treated animals, and 76 days in mic-PTX animals, respectively). We observed higher tissue uptake of drug following nab-PTX administration when compared to mic-PTX, with highest uptake after 4 hours post-treatment, and confirmed this lower uptake of mic-PTX using HPLC on digested tumor samples. Furthermore, apoptosis was not increased in tumor implants up to 24h post-treatment. Conclusion: Intraperitoneal administration of both nab-PTX and mic-PTX results in a significant anticancer efficacy and survival benefit in a mouse OC xenograft model.
Assuntos
Neoplasias Ovarianas , Humanos , Animais , Feminino , Camundongos , Neoplasias Ovarianas/tratamento farmacológico , Paclitaxel/farmacologia , Xenoenxertos , Apoptose , Espectrometria de Massas em Tandem , Linhagem Celular Tumoral , Modelos Animais de DoençasRESUMO
MR1T cells are a recently found class of T cells that recognize antigens presented by the major histocompatibility complex-I-related molecule MR1 in the absence of microbial infection. The nature of the self-antigens that stimulate MR1T cells remains unclear, hampering our understanding of their physiological role and therapeutic potential. By combining genetic, pharmacological, and biochemical approaches, we found that carbonyl stress and changes in nucleobase metabolism in target cells promote MR1T cell activation. Stimulatory compounds formed by carbonyl adducts of nucleobases were detected within MR1 molecules produced by tumor cells, and their abundance and antigenicity were enhanced by drugs that induce carbonyl accumulation. Our data reveal carbonyl-nucleobase adducts as MR1T cell antigens. Recognizing cells under carbonyl stress allows MR1T cells to monitor cellular metabolic changes with physiological and therapeutic implications.
Assuntos
Antígenos de Histocompatibilidade Classe I , Antígenos de Histocompatibilidade Menor , Animais , Humanos , Camundongos , Antígenos de Histocompatibilidade Classe I/imunologia , Antígenos de Histocompatibilidade Classe I/metabolismo , Ativação Linfocitária/imunologia , Antígenos de Histocompatibilidade Menor/metabolismo , Antígenos de Histocompatibilidade Menor/imunologia , Linfócitos T/imunologiaRESUMO
The usefulness of drafting a crisis preparedness plan (CPP) is now undisputed. This document aims to offer a practical tool for planning appropriate measures to be adopted by a hospital and/or more generally a health facility in order to be better prepared to face a critical situation. The tool is the result of concerted contributions of various experts in the field of emergency services management. The recommendations provided are tailored to a medium-to-large hospital with various specialties included, and should be adjusted as appropriate at the different levels of health care of the health facility. This document provides a list of issues that are considered by the contributors as essential themes that must be tackled in all CPPs for hospitals. Each issue represents concepts and problems that are likely to be universally present in all critical situations, emergency or disasters and cannot be set aside when drafting the CPP. The document provides specific measures and hints for preparedness in the event of a communicable disease epidemic, such as the possible influenza pandemic
Assuntos
Surtos de Doenças , Influenza Humana , Planejamento Hospitalar , Planejamento em Saúde , Atenção à Saúde , Planejamento em Desastres , Recursos em Saúde , Guia , Europa (Continente)RESUMO
The usefulness of drafting a crisis preparedness plan (CPP) is now undisputed. This document aims to offer a practical tool for planning appropriate measures to be adopted by a hospital and/or more generally a health facility in order to be better prepared to face a critical situation. The tool is the result of concerted contributions of various experts in the field of emergency services management. The recommendations provided are tailored to a medium-to-large hospital with various specialties included, and should be adjusted as appropriate at the different levels of health care of the health facility. This document provides a list of issues that are considered by the contributors as essential themes that must be tackled in all CPPs for hospitals. Each issue represents concepts and problems that are likely to be universally present in all critical situations, emergency or disasters and cannot be set aside when drafting the CPP. The document provides specific measures and hints for preparedness in the event of a communicable disease epidemic, such as the possible influenza pandemic